Adenosine receptors and the heart: Role in regulation of coronary blood flow and cardiac electrophysiology

Handbook of Experimental Pharmacology

Volumn 193, Issue , 2009, Pages 161-188

  Mustafa, S Jamal ^a   Morrison, R Ray ^b   Teng, Bunyen ^a   Pelleg, Amir ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

A 2B adenosine receptor; A1 adenosine receptor; A2A adenosine receptor; A3 adenosine receptor; Adenosine receptor knockout; Coronary artery; Endothelium; MAPK; Phospholipase C; Smooth muscle

Indexed keywords

2 [(2 CYCLOHEXYLETHYL)AMINO]ADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ANTIARRHYTHMIC AGENT; AUTACOID; BINODENOSON; CYCLIC AMP; DIAGNOSTIC AGENT; LEXISCAN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; POTASSIUM CHANNEL; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REGADENOSON; TECADENOSON; UNCLASSIFIED DRUG;

ADENOSINE RECEPTOR GENE; ADRENERGIC SYSTEM; ATRIOVENTRICULAR CONDUCTION; CHRONOTROPISM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST; DRUG EFFECT; DRUG EFFICACY; ENDOTHELIUM; GENE; GENE DELETION; GENE TARGETING; HEART; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART AUTOMATICITY; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRACORONARY INFUSION; KNOCKOUT MOUSE; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROVOCATION TEST; REVIEW; SENSITIVITY AND SPECIFICITY; SICK SINUS SYNDROME; SIGNAL TRANSDUCTION; SINUS NODE; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES; ANIMAL; PHYSIOLOGY; SECOND MESSENGER;

ADENOSINE; ANIMALS; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; HEART; HEART RATE; HUMANS; POTASSIUM CHANNELS; RECEPTORS, PURINERGIC P1; SECOND MESSENGER SYSTEMS;

EID: 70349312964     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-89615-9_6     Document Type: Review

References (175)

1. Abebe W, Makujina SR, Mustafa SJ (1994) Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am J Physiol 266:H2018-H2025
2. Abebe W, Hussain T, Olanrewaju H, Mustafa SJ (1995) Role of nitric oxide in adenosine receptormediated relaxation of porcine coronary artery. Am J Physiol 269:H1672-H1678
3. Ansari HR, Nadeem A, Tilley SL, Mustafa SJ (2007) Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta. Am J Physiol Heart Circ Physiol 293:H3448-H3455
4. Ansari H, Teng B, Nadeem A, Schnermann J, Mustafa S (2008) A1 adenosine receptor-activated protein kinase C signaling in A1 knock-out mice coronary artery smooth muscle cells. FASEB J 22: 1152.11
5. Ashton KJ, Nilsson U,Willems L, Holmgren K, Headrick JP (2003) Effects of aging and ischemia on adenosine receptor transcription in mouse myocardium. Biochem Biophys Res Commun 312:367-372
6. Ashton KJ, Peart JN, Morrison RR, Matherne GP, Blackburn MR, and Headrick JP (2007) Genetic modulation of adenosine receptor function and adenosine handling in murine hearts: insights and issues. J Mol Cell Cardiol 42:693-705
7. Belardinelli L, Isenberg G (1983) Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 53:287-297
8. Belardinelli L, Mattos EC, Berne RM (1981) Evidence for adenosine mediation of atrioventricular block in the ischemic canine myocardium. J Clin Invest 68:195-205
9. Belardinelli L, West GA, Clemo SHF (1987). Regulation of atrioventricular node function by adenosine. In: Gerlach E, Becker B (eds) Topics and perspectives of adenosine research. Springer, Berlin, pp 344-355
10. Belardinelli L, Giles WR, West A (1988) Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol 405:615-633
11. Belardinelli L, Shryock JC, Song Y, Wang D, Srinivas M (1995) Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J 9:359-365
12. Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, Ongini E, Olsson RA, Dennis DM (1998) The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284:1066-1073 (Pubitemid 28130836)
13. Berne RM (1963) Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 204:317-322
14. Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47: 807-813
15. Brignole M, Donateo P, Menozzi C (2003) The diagnostic value of ATP testing in patients with unexplained syncope. Europace 5:425-428
16. Bryan PT, Marshall JM (1999) Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia. J Physiol 514 (1): 163-175
17. Burnett D, Abi-Samra F, Vacek JL (1999) Use of intravenous adenosine as a noninvasive diagnostic test for sick sinus syndrome. Am Heart J 137:435-438
18. Carrega L, Saadjian AY, Mercier L, Zouher I, Berge-Lefranc JL, Gerolami V, Giaime P, Sbragia P, Paganelli F, Fenouillet E, Levy S, Guieu RP (2007) Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope. Heart Rhythm 4:870-876
19. Cerniway RJ, Yang Z, Jacobson MA, Linden J, Matherne GP (2001) Targeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. Am J Physiol Heart Circ Physiol 281:H1751-H1758
20. Cerqueira MD (2006) Advances in pharmacologic agents in imaging: new A2A receptor agonists. Curr Cardiol Rep 8:119-122
21. Cheung JW, Lerman BB (2003) CVT-510: a selective A1 adenosine receptor agonist. Cardiovasc Drug Rev 21:277-292
22. Cheung JW, Stein KM, Markowitz SM, Iwai S, Guttigoli AB, Shah BK, Yarlagadda RK, Lerman BB, Mittal S (2004) Significance of adenosine-induced atrioventricular block in patients with unexplained syncope. Heart Rhythm 1:664-668
23. Chio CC, Chang YH, Hsu YW, Chi KH, Lin WW (2004) PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal 16:565-575
24. Clemo HF, Belardinelli L (1986) Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node. Circ Res 59: 427-436 (Pubitemid 17211722)
25. Clemo HF, Bourassa A, Linden J, Belardinelli L (1987) Antagonism of the effects of adenosine and hypoxia on atrioventricular conduction time by two novel alkylxanthines: correlation with binding to adenosine A1 receptors. J Pharmacol Exp Ther 242:478-484
26. Conti JB, Belardinelli L, Curtis AB (1995) Usefulness of adenosine in diagnosis of tachyarrhythmias. Am J Cardiol 75:952-955
27. Dana A, Skarli M, Papakrivopoulou J, Yellon DM(2000) Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 86:989-997
28. Dennis D, Jacobson K, Belardinelli L (1992) Evidence of spare A1-adenosine receptors in guinea pig atrioventricular node. Am J Physiol 262:H661-H671
29. Denyer JC, Brown HF (1990) Pacemaking in rabbit isolated sino-atrial node cells during Cs+ block of the hyperpolarization-activated current if. J Physiol 429:401-409
30. Deussen A, Brand M, Pexa A, Weichsel J (2006) Metabolic coronary flow regulation-current concepts. Basic Res Cardiol 101:453-464
31. Dhalla AK, Shryock JC, Shreeniwas R, Belardinelli L (2003) Pharmacology and therapeutic applications of A1 adenosine receptor ligands. Curr Top Med Chem 3:369-385
32. DiFrancesco D, Borer JS (2007) The funny current: cellular basis for the control of heart rate. Drugs 67(Suppl 2):15-24
33. DiMarco JP, Sellers TD, Berne RM,West GA, Belardinelli L (1983) Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia. Circulation 68:1254-1263
34. Dobson JG, Jr., Fenton RA, Romano FD (1987) The cardiac anti-adrenergic effect of adenosine. Prog Clin Biol Res 230:331-343
35. Eckle T, Krahn T, Grenz A, Kohler D, Mittelbronn M, Ledent C, Jacobson MA, Osswald H, Thompson LF, Unertl K, Eltzschig HK (2007) Cardioprotection by ecto-5-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115:1581-1590
36. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, Eltzschig HK (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111:2024-2035
37. Fabritz L, Kirchhof P, Fortmuller L, Auchampach JA, Baba HA, Breithardt G, Neumann J, Boknik P, Schmitz W (2004) Gene dose-dependent atrial arrhythmias, heart block, and brady-cardiomyopathy in mice overexpressing A(3) adenosine receptors. Cardiovasc Res 62:: 500-508
38. Feoktistov I, Biaggioni I (1997) Adenosine A2B receptors. Pharmacol Rev 49:381-402
39. Flammang D, Pelleg A, Benditt DG (2005) The adenosine triphospate (ATP) test for evaluation of syncope of unknown origin. J Cardiovasc Electrophysiol 16:1388-1389
40. Flammang D, AMS Investigators (2006) The ATP test: a useful test for identifying the cardioinhibitory mechanism of syncope of unknown origin and for directing the therapy. Europace 8(Suppl 1):55
41. Flood AJ, Willems L, Headrick JP (2002) Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart. Cardiovasc Res 55:161-170
42. Fogaça RTH, Leal-Cardoso JH (1985) Effects of adenosine on digitalis induced arrhythmias. Braz J Med Biol Res 18:663A
43. Fragakis N, Iliadis I, Sidopoulos E, Lambrou A, Tsaritsaniotis E, Katsaris G (2007) The value of adenosine test in the diagnosis of sick sinus syndrome: susceptibility of sinus and atrioventricular node to adenosine in patients with sick sinus syndrome and unexplained syncope. Europace 9:559-562
44. Francis JE, Webb RL, Ghai GR, Hutchison AJ, Moskal MA, deJesus R, Yokoyama R, Rovinski SL, Contardo N, Dotson R, Barclay B, Stone GA, Jarvis MF (1991) Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines. J Med Chem 34:2570-2579
45. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W (2000) Structure and function of adenosine receptors and their genes. Naunyn-Schmiedeberg's Arch Pharmacol 362:364-374
46. Frieden M, Sollini M, Beny J (1999) Substance P and bradykinin activate different types of KCa currents to hyperpolarize cultured porcine coronary artery endothelial cells. J Physiol 519(2):361-371
47. Frobert O, Haink G, Simonsen U, Gravholt CH, Levin M, Deussen A (2006) Adenosine concentration in the porcine coronary artery wall and A2A receptor involvement in hypoxia-induced vasodilatation. J Physiol 570:375-384
48. Ge ZD, Peart JN, Kreckler LM, Wan TC, Jacobson MA, Gross GJ, Auchampach JA (2006) Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5-N-methylcarboxamide] reduces ischemia/ reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther 319:1200-1210
49. Geraets D, Kienzle M (1992) Clinical use of adenosine. Iowa Med 82:25-28
50. Gerlach E, Deuticke B (1966) Comparative studies on the formation of adenosine in the myocardium of different animal species in oxygen deficiency. Klin Wochenschr 44:1307-1310
51. Germack R, Dickenson JM (2004) Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes. Br J Pharmacol 141:329-339
52. Glavind-Kristensen M, Matchkov V, Hansen VB, Forman A, Nilsson H, Aalkjaer C (2004) KATPchannel- induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries. Br J Pharmacol 143:872-880
53. Hack SP, Christie MJ (2003) Adaptations in adenosine signaling in drug dependence: therapeutic implications. Crit Rev Neurobiol 15:235-274
54. Haq SE, Clerk A, Sugden PH (1998) Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart. FEBS Lett 434:305-308
55. Harrison GJ, Cerniway RJ, Peart J, Berr SS, Ashton K, Regan S, Paul Matherne G, Headrick JP (2002) Effects of A(3) adenosine receptor activation and gene knock-out in ischemic-reperfused mouse heart. Cardiovasc Res 53:147-155
56. Hasan AZ, Abebe W, Mustafa SJ (2000) Antagonism of coronary artery relaxation by adenosine A2A-receptor antagonist ZM241385. J Cardiovasc Pharmacol 35:322-325
57. Hayward E, Showler L, Soar J (2007) Aminophylline in bradyasystolic cardiac arrest. Emerg Med J 24:582-583
58. Headrick JP, Gauthier NS, Morrison RR, Matherne GP (2000) Chronotropic and vasodilatory responses to adenosine and isoproterenol in mouse heart: effects of adenosine A1 receptor overexpression. Clin Exp Pharmacol Physiol 27:185-190
59. Hein TW, Wang W, Zoghi B, Muthuchamy M, Kuo L (2001) Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. J Mol Cell Cardiol 33:271-282 (Pubitemid 32537926)
60. Hodgson JM, Dib N, Kern MJ, Bach RG, Barrett RJ (2007) Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist. Am J Cardiol 99:1507-1512
61. Hori M, Kitakaze M (1991) Adenosine, the heart, and coronary circulation. Hypertension 18: 565-574
62. Hove-Madsen L, Prat-Vidal C, Llach A, Ciruela F, Casado V, Lluis C, Bayes-Genis A, Cinca J, Franco R (2006) Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release. Cardiovasc Res 72:292-302
63. Hua X, Kovarova M, Chason KD, Nguyen M, Koller BH, Tilley SL (2007) Enhanced mast cell activation in mice deficient in the A2b adenosine receptor. J Exp Med 204:117-128
64. Hussain T, Mustafa SJ (1993) Regulation of adenosine receptor system in coronary artery: functional studies and cAMP. Am J Physiol 264:H441-H447
65. Hussain T, Mustafa SJ (1995) Binding of A1 adenosine receptor ligand [3H]8-cyclopentyl-1,3- dipropylxanthine in coronary smooth muscle. Circ Res 77:194-198
66. Hutchinson SA, Scammells PJ (2004) A(1) adenosine receptor agonists: medicinal chemistry and therapeutic potential. Curr Pharm Des 10:2021-2039
67. Hutchison AJ, Webb RL, Oei HH, Ghai GR, Zimmerman MB, Williams M (1989) CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther 251:47-55
68. Ingwall JS (2007) On substrate selection for ATP synthesis in the failing human myocardium. Am J Physiol Heart Circ Physiol 293:H3225-H3226
69. Ingwall JS, Weiss RG (2004) Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95:135-145
70. Iwai S, Markowitz SM, Stein KM, Mittal S, Slotwiner DJ, Das MK, Cohen JD, Hao SC, Lerman BB (2002) Response to adenosine differentiates focal from macroreentrant atrial tachycardia: validation using three-dimensional electroanatomic mapping. Circulation 106:2793-2799
71. Iwai S, Cantillon DJ, Kim RJ, Markowitz SM, Mittal S, Stein KM, Shah BK, Yarlagadda RK, Cheung JW, Tan VR, Lerman BB (2006) Right and left ventricular outflow tract tachycardias: evidence for a common electrophysiologic mechanism. J Cardiovasc Electrophysiol 17: 1052-1058
72. Kalyankrishna S, Malik KU (2003) Norepinephrine-induced stimulation of p38 mitogen-activated protein kinase is mediated by arachidonic acid metabolites generated by activation of cytosolic phospholipase A(2) in vascular smooth muscle cells. J Pharmacol Exp Ther 304:761-772
73. Keim S, Curtis AB, Belardinelli L, Epstein ML, Staples ED, Lerman BB (1992) Adenosineinduced atrioventricular block: a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways. J Am Coll Cardiol 19: 1005-1012
74. Kemp BK, Cocks TM (1999) Adenosine mediates relaxation of human small resistance-like coronary arteries via A2B receptors. Br J Pharmacol 126:1796-1800
75. Kim N, Chung J, Kim E, Han J (2003) Changes in the Ca2+-activated K+ channels of the coronary artery during left ventricular hypertrophy. Circ Res 93:541-547
76. Kirchhof P, Fabritz L, Fortmuller L, Matherne GP, Lankford A, Baba HA, Schmitz W, Breithardt G, Neumann J, Boknik P (2003) Altered sinus nodal and atrioventricular nodal function in freely moving mice overexpressing the A1 adenosine receptor. Am J Physiol Heart Circ Physiol 285:H145-H153
77. Kirsch GE, Codina J, Birnbaumer L, Brown AM (1990) Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 259:H820-H826 (Pubitemid 20310486)
78. Knaapen P, Germans T, Knuuti J, Paulus WJ, Dijkmans PA, Allaart CP, Lammertsma AA, Visser FC (2007) Myocardial energetics and efficiency: current status of the noninvasive approach. Circulation 115:918-927
79. Komalavilas P, Mehta S,Wingard CJ, Dransfield DT, Bhalla J,Woodrum JE, Molinaro JR, Brophy CM (2001) PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J Appl Physiol 91:1819-1827
80. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, ParmentierM(1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388:674-678
81. Lerman BB (1993) Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects. Circulation 87:382-390
82. Lerman BB, Belardinelli L, West GA, Berne RM, DiMarco JP (1986) Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation 74:270-280
83. Lerman BB, Wesley RC, Jr., DiMarco JP, Haines DE, Belardinelli L (1988) Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism. J Clin Invest 82:2127-2135
84. Lerman BB, Stein K, Engelstein ED, Battleman DS, Lippman N, Bei D, Catanzaro D (1995) Mechanism of repetitive monomorphic ventricular tachycardia. Circulation 92:421-429
85. Lerman BB, Stein KM, Markowitz SM (1997) Mechanisms of idiopathic left ventricular tachycardia. J Cardiovasc Electrophysiol 8:571-583
86. Lerman BB, Stein KM, Markowitz SM, Mittal S, Slotwiner DJ (2000) Ventricular arrhythmias in normal hearts. Cardiol Clin 18:265-291
87. Li J, Fenton RA,Wheeler HB, Powell CC, Peyton BD, Cutler BS, Dobson JG, Jr. (1998) Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J Surg Res 80:357-364
88. Li PL, Zhang DX, Zou AP, Campbell WB (1999) Effect of ceramide on KCa channel activity and vascular tone in coronary arteries. Hypertension 33:1441-1446
89. Lindsay BD (2007) Focal and macroreentrant atrial tachycardia: from bench to bedside and back to the bench again. Heart Rhythm 4:1361-1363
90. Liu Y, Terata K, Rusch NJ, Gutterman DD (2001) High glucose impairs voltage-gated K(+) channel current in rat small coronary arteries. Circ Res 89:146-152
91. Lowes VL, Ip NY, Wong YH (2002) Integration of signals from receptor tyrosine kinases and G protein-coupled receptors. Neurosignals 11:5-19
92. Mader TJ, Menegazzi JJ, Betz AE, Logue ES, Callaway CW, Sherman LD (2006) Adenosine A1 receptor antagonism hastens the decay in ventricular fibrillation waveform morphology during porcine cardiac arrest. Resuscitation 71:254-259
93. Makujina SR, Sabouni MH, Bhatia S, Douglas FL, Mustafa SJ (1992) Vasodilatory effects of adenosine A2 receptor agonists CGS 21680 and CGS 22492 in human vasculature. Eur J Pharmacol 221:243-247. Marala RB, Mustafa SJ (1995a) Adenosine A1 receptor-induced upregulation of protein kinase C: role of pertussis toxin-sensitive G protein(s). Am J Physiol 269:H1619-H1624
94. Marala RB, Mustafa SJ (1995b) Adenosine analogues prevent phorbol ester-induced PKC depletion in porcine coronary artery via A1 receptor. Am J Physiol 268:H271-H277
95. Marala RB, Mustafa SJ (1995c) Modulation of protein kinase C by adenosine: involvement of adenosine A1 receptor-pertussis toxin sensitive nucleotide binding protein system. Mol Cell Biochem 149-150:51-58
96. Markowitz SM, Nemirovksy D, Stein KM, Mittal S, Iwai S, Shah BK, Dobesh DP, Lerman BB (2007) Adenosine-insensitive focal atrial tachycardia: evidence for de novo micro-re-entry in the human atrium. J Am Coll Cardiol 49:1324-1333
97. Markowitz SM, Stein KM,Mittal S, Slotwiner DJ, Lerman BB (1999) Differential effects of adenosine on focal and macroreentrant atrial tachycardia. J Cardiovasc Electrophysiol 10:489-502
98. Meloche S, Landry J, Huot J, Houle F, Marceau F, Giasson E (2000) p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol Heart Circ Physiol 279:H741-H751
99. Mittal S, Stein KM, Markowitz SM, Iwai S, Guttigoli A, Lerman BB (2004) Single-stage adenosine tilt testing in patients with unexplained syncope. J Cardiovasc Electrophysiol 15:637-640
100. Morrison RR, Talukder MA, Ledent C, Mustafa SJ (2002) Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors. Am J Physiol Heart Circ Physiol 282:H437-H444
101. Morrison RR, Teng B, Oldenburg PJ, Katwa LC, Schnermann JB, Mustafa SJ (2006) Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes. Am J Physiol Heart Circ Physiol 291:H1875-H1882
102. Morrison RR, Tan XL, Ledent C, Mustafa SJ, Hofmann PA (2007) Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol 293:H2523-H2529
103. Mustafa SJ, Abebe W (1996) Coronary vasodilation by adenosine: receptor subtypes and mechanisms of action. Drug Dev Res 39:308-313
104. Mustafa SJ, Askar AO (1985) Evidence suggesting an Ra-type adenosine receptor in bovine coronary arteries. J Pharmacol Exp Ther 232:49-56
105. Mutafova-Yambolieva VN, Keef KD (1997) Adenosine-induced hyperpolarization in guinea pig coronary artery involves A2b receptors and KATP channels. Am J Physiol 273:H2687-H2695
106. Neubauer S (2007) The failing heart-an engine out of fuel. N Engl J Med 356:1140-1151
107. Niiya K, Uchida S, Tsuji T, Olsson RA (1994) Glibenclamide reduces the coronary vasoactivity of adenosine receptor agonists. J Pharmacol Exp Ther 271:14-19
108. Nitenberg A, Durand E, Delatour B, Sdiri W, Raha S, Lafont A (2007) Postocclusion hyperemia provides a better estimate of coronary reserve than intracoronary adenosine in patients with coronary artery stenosis. J Invasive Cardiol 19:390-394
109. Nogami A (2002) Idiopathic left ventricular tachycardia: assessment and treatment. Card Electrophysiol Rev 6:448-457
110. Olanrewaju HA, Mustafa SJ (2000) Adenosine A(2A) and A(2B) receptors mediated nitric oxide production in coronary artery endothelial cells. Gen Pharmacol 35:171-177
111. Olanrewaju HA, Qin W, Feoktistov I, Scemama JL, Mustafa SJ (2000) Adenosine A(2A) and A(2B) receptors in cultured human and porcine coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 279:H650-H656
112. Olanrewaju HA, Gafurov BS, Lieberman EM (2002) Involvement of K+ channels in adenosine A2A and A2B receptor-mediated hyperpolarization of porcine coronary artery endothelial cells. J Cardiovasc Pharmacol 40:43-49
113. Olsson RA (1970) Changes in content of purine nucleoside in canine myocardium during coronary occlusion. Circ Res 26:301-306
114. Ono K, Han J (2000) The p38 signal transduction pathway: activation and function. Cell Signal 12:1-13
115. Parry SW, Nath S, Bourke JP, Bexton RS, Kenny RA (2006) Adenosine test in the diagnosis of unexplained syncope: marker of conducting tissue disease or neurally mediated syncope? Eur Heart J 27:1396-1400
116. Peart JN, Headrick JP (2007) Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 114:208-221
117. Pelleg A, Belardinelli L (1993) Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc Res 27:54-61
118. Pelleg A, Kutalek SP (1997) Adenosine in the mammalian heart: nothing to get excited about. Trends Pharmacol Sci 18:236-238
119. Peterman C, Sanoski CA (2005) Tecadenoson: a novel, selective A1 adenosine receptor agonist. Cardiol Rev 13:315-321
120. Pelleg A, Mitamura H, Mitsuoka T, Michelson EL, Dreifus LS (1986) Effects of adenosine and adenosine 5-triphosphate on ventricular escape rhythm in the canine heart. J Am Coll Cardiol 8:1145-1151
121. Pelleg A, Hurt C, Miyagawa A, Michelson EL, Dreifus LS (1990a) Differential sensitivity of cardiac pacemakers to exogenous adenosine in vivo. Am J Physiol 258:H1815-H1822
122. Pelleg A, Hurt CM, Michelson EL (1990b) Cardiac effects of adenosine and ATP. Ann N Y Acad Sci 603:19-30
123. Pelleg A, Hurt CM, Hewlett EL (1996) ATP shortens atrial action potential duration in the dog: role of adenosine, the vagus nerve, and G protein. Can J Physiol Pharmacol 74:15-22
124. Pelleg A, Katchanov G, Xu J (1997) Autonomic neural control of cardiac function: modulation by adenosine and adenosine 5-triphosphate. Am J Cardiol 79:11-14
125. Pelleg A, Pennock RS, Kutalek SP (2002) Proarrhythmic effects of adenosine: one decade of clinical data. Am J Ther 9:141-147
126. Quayle JM, Nelson MT, Standen NB (1997) ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77:1165-1232
127. Rahman A, Anwar KN, Minhajuddin M, Bijli KM, Javaid K, True AL, Malik AB (2004) cAMP Targeting of p38 MAP kinase Inhibits thrombin-induced NF-{kappa}B activation and ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 287:L1017-L1024
128. Ramagopal MV, Chitwood RW Jr, Mustafa SJ (1988) Evidence for an A2 adenosine receptor in human coronary arteries. Eur J Pharmacol 151:483-486
129. Ray CJ, Marshall JM (2006) The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. J Physiol 570:85-96
130. Reichelt ME, Willems L, Molina JG, Sun CX, Noble JC, Ashton KJ, Schnermann J, Blackburn MR, Headrick JP (2005) Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance. Circ Res 96:363-367
131. Rekik M, Mustafa JS (2003) Modulation of A2A adenosine receptors and associated Galphas proteins by ZM 241385 treatment of porcine coronary artery. J Cardiovasc Pharmacol 42:736-744
132. Resh W, Feuer J, Wesley RC, Jr. (1992) Intravenous adenosine: a noninvasive diagnostic test for sick sinus syndrome. Pacing Clin Electrophysiol 15:2068-2073
133. Robinson AJ, Dickenson JM (2001) Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells. Eur J Pharmacol 413:151-161
134. Rogers PA, Chilian WM, Bratz IN, Bryan RM, Jr., Dick GM (2007) H2O2 activates redox- and 4- aminopyridine-sensitive Kv channels in coronary vascular smooth muscle. Am J Physiol Heart Circ Physiol 292:H1404-H1411
135. Rubio R, Wiedmeier VT, Berne RM (1974) Relationship between coronary flow and adenosine production and release. J Mol Cell Cardiol 6:561-566
136. Saadjian AY, Levy S, Franceschi F, Zouher I, Paganelli F, Guieu RP (2002) Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation 106:569-574
137. Salloum FN, Das A, Thomas CS, Yin C, Kukreja RC (2007) Adenosine A(1) receptor mediates delayed cardioprotective effect of sildenafil in mouse. J Mol Cell Cardiol 43:545-551
138. Sanders L, Rakovic S, Lowe M, Mattick PA, Terrar DA (2006) Fundamental importance of Na+-Ca2+ exchange for the pacemaking mechanism in guinea-pig sino-atrial node. J Physiol 571:639-649
139. Schrader J, Baumann G, Gerlach E (1977) Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch 372:29-35
140. Schulte G, Fredholm BB (2002) Adenosine A2B receptors activate extracellular signal-regulated kinase ERK 1/2 and stress-activated protein kinase p38. In: XIVth World Congress of Pharmacology, San Francisco, CA, 7-12 July 2002, 44(2):A262
141. Schulte G, Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15:813-827
142. Shen WK, Kurachi Y (1995) Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology. Mayo Clin Proc 70:274-291
143. Shen WK, Hammill SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, Wood DL, Bailey KR, Low PA, Gersh BJ (1996) Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 28:146-154
144. Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, Ongini E, Baker SP, Belardinelli L (1998) A2A-adenosine receptor reserve for coronary vasodilation. Circulation 98:711-718 (Pubitemid 28387498)
145. Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL (1998) Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 286:611-618 (Pubitemid 29003446)
146. Song Y, Thedford S, Lerman BB, Belardinelli L (1992) Adenosine-sensitive afterdepolarizations and triggered activity in guinea pig ventricular myocytes. Circ Res 70:743-753
147. Song Y,Wu L, Shryock JC, Belardinelli L (2002) Selective attenuation of isoproterenol-stimulated arrhythmic activity by a partial agonist of adenosine A1 receptor. Circulation 105:118-123
148. Sun Park W, Kyoung Son Y, Kim N, Boum Youm J, Joo H, Warda M, Ko JH, Earm YE, Han J (2006) The protein kinase A inhibitor, H-89, directly inhibits KATP and Kir channels in rabbit coronary arterial smooth muscle cells. Biochem Biophys Res Commun 340:1104-1110 (Pubitemid 43083392)
149. Taegtmeyer H, Wilson CR, Razeghi P, Sharma S (2005) Metabolic energetics and genetics in the heart. Ann N Y Acad Sci 1047:208-218
150. Talukder MA, Morrison RR, Jacobson MA, Jacobson KA, Ledent C, Mustafa SJ (2002a) Targeted deletion of adenosine A(3) receptors augments adenosine-induced coronary flow in isolated mouse heart. Am J Physiol Heart Circ Physiol 282:H2183-H2189
151. Talukder MA, Morrison RR, Mustafa SJ (2002b) Comparison of the vascular effects of adenosine in isolated mouse heart and aorta. Am J Physiol Heart Circ Physiol 282:H49-H57
152. Talukder MA, Morrison RR, Ledent C, Mustafa SJ (2003) Endogenous adenosine increases coronary flow by activation of both A2A and A2B receptors in mice. J Cardiovasc Pharmacol 41:562-570
153. Tang L, Parker M, Fei Q, Loutzenhiser R (1999) Afferent arteriolar adenosine A2a receptors are coupled to KATP in in vitro perfused hydronephrotic rat kidney. Am J Physiol 277:F926-F933
154. Tawfik HE, Schnermann J, Oldenburg PJ, Mustafa SJ (2005) Role of A1 adenosine receptors in regulation of vascular tone. Am J Physiol Heart Circ Physiol 288:H1411-H1416
155. Tawfik HE, Teng B, Morrison RR, Schnermann J, Mustafa SJ (2006) Role of A1 adenosine receptor in the regulation of coronary flow. Am J Physiol Heart Circ Physiol 291:H467-H472
156. Teng B, Qin W, Ansari HR, Mustafa SJ (2005) Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery. Am J Physiol Heart Circ Physiol 288:H2574-H2580
157. Teng B, Ledent C, Mustafa SJ (2008) Up-regulation of A(2B) adenosine receptor in A(2A) adenosine receptor knockout mouse coronary artery. J Mol Cell Cardiol 44:905-914
158. Tune JD, Gorman MW, Feigl EO (2004) Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 97:404-415
159. Viskin S, Belhassen B, Roth A, Reicher M, Averbuch M, Sheps D, Shalabye E, Laniado S (1993) Aminophylline for bradyasystolic cardiac arrest refractory to atropine and epinephrine. Ann Intern Med 118:279-281
160. Viskin S, Rosso R, Rogowski O, Belhassen B, Levitas A, Wagshal A, Katz A, Fourey D, Zeltser D, Oliva A, Pollevick GD, Antzelevitch C, Rozovski U (2006) Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J 27:469-475
161. Wang J, Whitt SP, Rubin LJ, Huxley VH (2005) Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes. Microcirculation 12: 313-326
162. Watts SW, Florian JA, Monroe KM (1998) Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction. J Pharmacol Exp Ther 286:1431-1438
163. Wilden PA, Agazie YM, Kaufman R, Halenda SP (1998) ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol 275: H1209-H1215
164. Xu J, Tong H, Wang L, Hurt CM, Pelleg A (1993) Endogenous adenosine, A1 adenosine receptor, and pertussis toxin sensitive guanine nucleotide binding protein mediate hypoxia induced AV nodal conduction block in guinea pig heart in vivo. Cardiovasc Res 27:134-140
165. Xu J, Wang L, Hurt CM, Pelleg A (1994) Endogenous adenosine does not activate ATP-sensitive potassium channels in the hypoxic guinea pig ventricle in vivo. Circulation 89:1209-1216
166. Xu J, Hurt CM, Pelleg A (1995) Digoxin-induced ventricular arrhythmias in the guinea pig heart in vivo: evidence for a role of endogenous catecholamines in the genesis of delayed afterdepolarizations and triggered activity. Heart Vessels 10:119-127
167. Xu J, Kussmaul W, Kurnik PB, Al-Ahdav M, Pelleg A (2005) Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in the dog. V. Role of purinergic receptors. Am J Physiol Regul Integr Comp Physiol 288:R651-R655
168. Yang ZW, Wang J, Zheng T, Altura BT, Altura BM (2000) Low [Mg2+]o induces contraction of cerebral arteries: roles of tyrosine and mitogen-activated protein kinases. Am J Physiol Heart Circ Physiol 279:H185-H194 (Pubitemid 30616659)
169. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K (2006) The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116:1913-1923
170. Yang D, Koupenova M, McCrann DJ, Kopeikina KJ, Kagan HM, Schreiber BM, Ravid K (2008) The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci USA 105: 792-796
171. Zablocki JA,Wu L, Shryock J, Belardinelli L (2004) Partial A(1) adenosine receptor agonists from a molecular perspective and their potential use as chronic ventricular rate control agents during atrial fibrillation (AF). Curr Top Med Chem 4:839-854
172. Zatta AJ, Headrick JP (2005) Mediators of coronary reactive hyperaemia in isolated mouse heart. Br J Pharmacol 144:576-587
173. Zaza A, Rocchetti M, DiFrancesco D (1996) Modulation of the hyperpolarization-activated current (I(f)) by adenosine in rabbit sinoatrial myocytes. Circulation 94:734-741
174. Zhao Z, Makaritsis K, Francis CE, Gavras H, Ravid K (2000) A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim Biophys Acta 1500:280-290
175. Zhao TC, Hines DS, Kukreja RC (2001) Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 280:H1278-H1285